Young person and adult screening KPI data: Q3 summary factsheets (1 October to 31 December 2021)
Updated 23 March 2023
Applies to England
© Crown copyright 2023
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/nhs-screening-programmes-kpi-reports-2021-to-2022/young-person-and-adult-screening-kpi-data-q3-summary-factsheets-1-october-to-31-december-2021--2
Please be aware that this data covers the period through the COVID-19 pandemic. Provider performance should therefore be interpreted with caution.
In addition to this, some providers were justifiably not able to make timely data returns or validate their data in this period. We recommend looking at the historic trend data of services before the COVID-19 pandemic to help interpret the data.
This report should be read alongside the full key performance indicator (KPI) data tables published each quarter.
1. Abdominal aortic aneurysm screening
1.1 KPI AA2: coverage: initial screen
National performance of AA2 in Q3 was 35.9%. AA2 is an annual indicator and quarterly figures are cumulative from Q1 to Q4. England performance is shown in the trend graph below.
Due to the ongoing coronavirus response and restoration of screening this KPI has been impacted. Performance against the KPI has been affected by when providers restarted primary screening, increased appointment lengths, access to venues and availability of screening staff.
Quarter 3 performance
| Reporting period | 1 October to 31 December 2021 |
|---|---|
| Numerator | 112,153 |
| Denominator | 312,169 |
| Performance | 35.9% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 26.4% |
| Midlands and East | 39.8% |
| North | 24.9% |
| South | 48.1% |
| England | 35.9% |
1.2 KPI AA3: coverage: annual surveillance scan
National performance of AA3 was withdrawn from publication in Q1 and Q2 2020 to 2021, and also Q1 2021 to 2022. This was due to the impact of the COVID-19 pandemic on screening activity that occurred during these periods.
The trend graph below shows that England AA3 in Q3 was 91.5%, above the acceptable threshold of 85%.
Quarter 3 performance
| Reporting period | 1 October to 31 December 2021 |
|---|---|
| Numerator | 3,069 |
| Denominator | 3,355 |
| Performance | 91.5% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 83.9% |
| Midlands and East | 93.6% |
| North | 90.5% |
| South | 91.4% |
| England | 91.5% |
1.3 KPI AA4: coverage: quarterly surveillance scan
National performance of AA4 was withdrawn from publication in Q1 and Q2 2020 to 2021 due to the impact of the COVID-19 pandemic on screening activity. The trend graph below shows that England AA4 in Q3 2021 to 2022 was 93.3%, higher than the previous quarter and above the acceptable threshold of 90%.
30 out of 38 screening services met the acceptable threshold, and 17 of those met the achievable threshold of 95%.
Quarter 3 performance
| Reporting period | 1 October to 31 December 2021 |
|---|---|
| Numerator | 2,680 |
| Denominator | 2,871 |
| Performance | 93.3% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 89.5% |
| Midlands and East | 93.9% |
| North | 91.1% |
| South | 95.0% |
| England | 93.3% |
2. Diabetic eye screening
2.1 KPI DE1: uptake: routine digital screening
National performance of DE1 in Q3 was 77.6%, higher than the previous 5 quarters. The trend graph below shows that England DE1 performance was above the acceptable threshold of 75% for the first time since Q1 2020 to 2021. All 57 screening services submitted data. DE1 is an annual rolling figure.
Due to the ongoing coronavirus response and restoration of screening this KPI may be impacted. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.
Quarter 3 performance
| Reporting period | 1 October to 31 December 2021 |
|---|---|
| Numerator | 2,066,288 |
| Denominator | 2,661,700 |
| Performance | 77.6% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 77.2% |
| Midlands and East | 75.4% |
| North | 76.3% |
| South | 82.6% |
| England | 77.6% |
2.2 KPI DE2: test: timeliness of results letters
National performance of DE2 in Q3 was 96.7%, lower than the previous quarter. The trend graph below shows that England DE2 performance has remained above the achievable threshold of 95% since 1 October 2018. All 57 screening services submitted data. 55 services met the acceptable threshold of 70% and 48 met the achievable threshold of 95%.
Due to the ongoing coronavirus response and restoration of screening this KPI may be impacted. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.
Quarter 3 performance
| Reporting period | 1 October to 31 December 2021 |
|---|---|
| Numerator | 643,273 |
| Denominator | 665,263 |
| Performance | 96.7% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 98.2% |
| Midlands and East | 98.8% |
| North | 91.6% |
| South | 98.9% |
| England | 96.7% |
2.3 KPI DE3: intervention/treatment: timely consultation for people with diabetes who are screen positive
National performance of DE3 in Q3 was 66.6%, lower than the previous 4 quarters. The trend graph below shows that England DE3 performance has remained below the acceptable threshold of 80% since 1 April 2018. All 57 screening services submitted data and 10 met the acceptable threshold.
Due to the ongoing coronavirus response and restoration of screening this KPI may be impacted. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.
Quarter 3 performance
| Reporting period | 1 October to 31 December 2021 |
|---|---|
| Numerator | 1,564 |
| Denominator | 2,348 |
| Performance | 66.6% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 70.5% |
| Midlands and East | 65.2% |
| North | 67.3% |
| South | 64.5% |
| England | 66.6% |
3. Bowel cancer screening
3.1 KPI BCS1: uptake
National performance of BCS1 in Q3 was 66.8%, lower than the previous quarter. Publication of BCS1 was withdrawn for Q1 2020 to 2021 due to the impact of COVID-19 on screening activity. The trend graph below shows that England BCS1 performance has remained above the acceptable threshold of 52% since 1 April 2018.
Out of 64 screening services, 61 of them met the acceptable threshold and 56 met the achievable threshold of 60%.
Quarter 3 performance
| Reporting period | 1 October to 31 December 2021 |
|---|---|
| Numerator | 917,175 |
| Denominator | 1,372,475 |
| Performance | 66.8% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| Eastern | 69.1% |
| London | 54.9% |
| Midlands and North West | 66.7% |
| North East | 68.3% |
| Southern | 69.5% |
| England | 66.8% |
3.2 KPI BCS2: coverage
National performance of BCS2 in Q2 was 69.5%, the highest published level recorded for this KPI. There have been changes made to this indicator in the Public Health Outcomes Framework. See the corresponding data tables for Q1 2021 to 2022 for full details.
BCS2 is available 6 months (2 quarters) in arrears. The trend graph below shows England BCS2 performance since 1 April 2018. There are no thresholds set for this KPI.
Coverage ranged from 62.0% in London to 72.5% in the South.
Quarter 2 performance
| Reporting period | 1 July to 30 September 2021 |
|---|---|
| Numerator | 6,363,632 |
| Denominator | 9,160,675 |
| Performance | 69.5% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 62.0% |
| Midlands and East | 69.8% |
| North | 69.2% |
| South | 72.5% |
| England | 69.5% |
4. Breast screening
4.1 KPI BS1: uptake
National performance of BS1 in Q3 was 54.5%. The England trend graph below shows that publication of this KPI was withdrawn from Q1 to Q4 2020 to 2021 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services.
Quarter 3 performance
| Reporting period | 1 October to 31 December 2021 |
|---|---|
| Numerator | 427,184 |
| Denominator | 784,204 |
| Performance | 54.5% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 40.9% |
| Midlands and East | 54.8% |
| North | 56.6% |
| South | 59.7% |
| England | 54.5% |
4.2 KPI BS2: uptake: screening round length
National performance of BS2 in Q3 was 30.7%. The England trend graph below shows that publication of this KPI was withdrawn from Q1 to Q4 2020 to 2021 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services.
Quarter 3 performance
| Reporting period | 1 October to 31 December 2021 |
|---|---|
| Numerator | 179,980 |
| Denominator | 585,879 |
| Performance | 30.7% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 11.6% |
| Midlands and East | 35.7% |
| North | 24.6% |
| South | 41.4% |
| England | 30.7% |
5. Cervical screening
5.1 KPI CS1: coverage under 50 years
National performance of CS1 in Q3 was 68.1%, lower than the previous 3 quarters. The trend graph below shows that CS1 performance has remained below the acceptable threshold of 80% since 1 April 2018.
On April 1 2021, 38 clinical commissioning groups (CCGs) merged creating 9 new ones, resulting in a total of 106 CCGs in England. None of the 106 CCGs met the acceptable threshold.
Quarter 3 performance
| Reporting period | 1 October to 31 December 2021 |
|---|---|
| Numerator | 7,076,605 |
| Denominator | 10,396,343 |
| Performance | 68.1% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 60.3% |
| Midlands and East | 69.7% |
| North | 70.2% |
| South | 70.8% |
| England | 68.1% |
5.2 KPI CS2: coverage 50 years and above
National performance of CS2 in Q3 was 74.8%, slightly lower than the previous quarter. The trend graph below shows that CS2 performance has remained below the acceptable threshold of 80% since 1 April 2018.
On April 1 2021, 38 CCGs merged creating 9 new ones, resulting in a total of 106 CCGs in England. None of the 106 CCGs met the acceptable threshold.
Quarter 3 performance
| Reporting period | 1 October to 31 December 2021 |
|---|---|
| Numerator | 3,957,213 |
| Denominator | 5,288,396 |
| Performance | 74.8% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 71.5% |
| Midlands and East | 75.6% |
| North | 75.1% |
| South | 75.5% |
| England | 74.8% |